Amdoxovir is a nucleoside reverse transcriptase inhibitor (NRTI) undergoing research for the treatment of HIV/AIDS. It was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia). It is being developed by RFS Pharma. Currently, it is in Phase II clinical studies.
Amdoxovir could eventually be available on the market as an HIV/AIDS treatment
The context says that Amdoxovir is undergoing research as a treatment for HIV/AIDS and is in phase 2 of clinical studies, so it is possible that it will finish the clinical research process and be approved as a treatment to be available on the market. The computer likely did not understand the logical train of thought.